Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults

NCT06919926 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hippocampal Overactivity
Dementia

Interventions

DRUG: AGB101
DRUG: Placebo

Sponsor

Johns Hopkins University

Collaborators

[object Object]
[object Object]